ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,760Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 122

$1.15M Total Retail Price of All Prescriptions

Rank: 1 out of 122

369 Patients Receiving at Least One Drug in Part D
42%Patients 65 Years and Older
88% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Missouri
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 369 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

2% of this provider’s 2,756 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$118 was the average price of a prescription from this provider, compared to $90 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Missouri
RENVELA 564 117 1 4
AMLODIPINE BESYLATE 468 135 2 1
LISINOPRIL 355 86 3 2
SENSIPAR 326 94 4 9
PROSOL 274 80 5 42
FUROSEMIDE 262 120 6 3
SIMVASTATIN 241 63 7 7
METOPROLOL TARTRATE 236 85 8 8
RANITIDINE HCL 206 56 9 39
GABAPENTIN 191 30 10 24
CALCIUM ACETATE 190 61 11 15
PENTOXIFYLLINE 176 25 12 79
NEXIUM 175 25 13 36
OMEPRAZOLE 171 40 14 13
PREDNISONE 167 70 15 23
ZOLPIDEM TARTRATE 165 0 16 32
ALLOPURINOL 162 79 17 11
LOSARTAN POTASSIUM 157 70 18 10
METOPROLOL SUCCINATE 148 69 19 22
HYDRALAZINE HCL 145 44 20 14
TRAMADOL HCL 142 37 21 28
CALCITRIOL 141 71 22 5
WARFARIN SODIUM 139 26 23 30
CLONIDINE HCL 139 34 23 12
CARVEDILOL 125 16 25 6
ATORVASTATIN CALCIUM 118 59 26 19
ISOSORBIDE MONONITRATE ER 111 21 27 48
MIDODRINE HCL 106 30 28 109
DIOVAN 106 12 28 33
MEGESTROL ACETATE 105 48 R 30 77
PRAVASTATIN SODIUM 103 23 31 31
ATENOLOL 102 0 32 38
LANTUS 92 0 33 52
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 31 34 26
LEVOTHYROXINE SODIUM 83 31 35 16
CLOPIDOGREL 81 14 36 61
LABETALOL HCL 81 17 36 41
PLAVIX 76 11 38 83
LOVASTATIN 73 34 39 47
LIPITOR 73 29 39 53
INSULIN SYRINGE 70 0 41 78
AZITHROMYCIN 69 21 42 56
TRAZODONE HCL 66 14 43 81
PEN NEEDLE 60 0 44 62
GENTAMICIN SULFATE 59 20 45 81
FOSRENOL 52 13 46 150
NIFEDIPINE ER 51 38 47 27
HYDROXYZINE HCL 50 0 R 48 84
LOPERAMIDE 50 12 48 111
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.